Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Spratt

Showing results (301-310 of 498) with videos related to

Pageof 50
Sort By:
NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
Prostate Cancer and Prostatic Diseases|July 6, 2021
A transcriptomic model for homologous recombination deficiency in prostate cancerAdam B Weiner, Yang Liu, Matthew McFarlane, et al.
The Lancet. Oncology|December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportDaniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
European Urology|July 8, 2018
Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell CarcinomaAaron M Udager, Andrew S McDaniel, Daniel H Hovelson, et al.
Human Pathology|December 12, 2018
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinomaCaroline T Simon, Stephanie L Skala, Alon Z Weizer, et al.
JAMA Network Open|October 15, 2024
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical TrialSoumyajit Roy, Shawn Malone, Kevin Wing, et al.
Cancer|January 7, 2020
Genomic and clinical characterization of stromal infiltration markers in prostate cancerBrandon A Mahal, Mohammed Alshalalfa, Shuang G Zhao, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
Pageof 50

Showing results (301-310 of 498) with videos related to

Sort By:
Pageof 50
NPJ Breast Cancer|August 26, 2017
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancerCorey Speers, Shuang G Zhao, Ben Chandler, et al.
European Urology Oncology|August 4, 2024
Association Between the Decipher Genomic Classifier and Prostate Cancer Outcome in the Real-world SettingMichael S Leapman, Julian Ho, Yang Liu, et al.
Prostate Cancer and Prostatic Diseases|July 6, 2021
A transcriptomic model for homologous recombination deficiency in prostate cancerAdam B Weiner, Yang Liu, Matthew McFarlane, et al.
The Lancet. Oncology|December 7, 2017
An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium reportDaniel E Spratt, Whitney H Beeler, Fabio Y de Moraes, et al.
European Urology|July 8, 2018
Frequent PD-L1 Protein Expression and Molecular Correlates in Urinary Bladder Squamous Cell CarcinomaAaron M Udager, Andrew S McDaniel, Daniel H Hovelson, et al.
Human Pathology|December 12, 2018
Clinical utility and concordance of upper urinary tract cytology and biopsy in predicting clinicopathological features of upper urinary tract urothelial carcinomaCaroline T Simon, Stephanie L Skala, Alon Z Weizer, et al.
JAMA Network Open|October 15, 2024
Prior Local Therapy and First-Line Apalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of the SPARTAN Randomized Clinical TrialSoumyajit Roy, Shawn Malone, Kevin Wing, et al.
Cancer|January 7, 2020
Genomic and clinical characterization of stromal infiltration markers in prostate cancerBrandon A Mahal, Mohammed Alshalalfa, Shuang G Zhao, et al.
European Urology Oncology|August 15, 2019
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate CancerMelody J Xu, Zachary Kornberg, Adam J Gadzinski, et al.
Cancer|December 13, 2017
Travel distance and stereotactic body radiotherapy for localized prostate cancerBrandon A Mahal, Yu-Wei Chen, Roshan V Sethi, et al.
Pageof 50